Shenzhen Tongyi Industry's (SZSE:300538) Earnings May Just Be The Starting Point
Shenzhen Tongyi Industry's (SZSE:300538) Earnings May Just Be The Starting Point
Shenzhen Tongyi Industry Co., Ltd. (SZSE:300538) just reported healthy earnings but the stock price didn't move much. Our analysis suggests that investors might be missing some promising details.
深圳同益股份有限公司(SZSE:300538)剛剛公佈了健康的收益,但股價沒有太大變動。我們的分析表明投資者可能忽視了一些有前景的細節。
![1724657950641](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240826/42858180-0-c96e12b2899cf2afd7a67de67e5bdea0.webp/bigjpg)
The Impact Of Unusual Items On Profit
除了稀釋之外,還應該注意的是,萬集科技在過去12個月中因不尋常項目獲得了價值人民幣3.5萬元的利潤。雖然我們希望看到利潤增加,但當這些不尋常項目對利潤做出重大貢獻時,我們會更加謹慎。我們對全球大部分上市公司的數據進行了分析,發現不尋常項目往往是一次性的。這正如我們所期望的那樣,因爲這些提升被描述爲"不尋常"。相對於其利潤而言,萬集科技在2021年12月前的不尋常項目貢獻大。因此,我們可以推斷出,這些不尋常項目正在使其財務利潤顯著增強。
For anyone who wants to understand Shenzhen Tongyi Industry's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by CN¥5.2m due to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. If Shenzhen Tongyi Industry doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.
對於任何想了解深圳同益股份業績的人來說,除了法定數字之外,還重要注意到,在過去的十二個月裏,法定利潤因爲飛凡項目減少了520萬人民幣。雖然飛凡項目的扣除令人失望,但其中也有積極方面。我們調查了成千上萬家上市公司,發現飛凡項目往往是一次性的,這正是會計術語所暗示的。如果深圳同益股份不再發生這些異常費用,其他條件不變,我們預計其盈利將在未來一年內增加。
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Shenzhen Tongyi Industry.
注意:我們始終建議投資者檢查資產負債表的強度。單擊此處查看我們對深圳同益股份資產負債表分析。
Our Take On Shenzhen Tongyi Industry's Profit Performance
我們對深圳同益股份的利潤表現的看法
Because unusual items detracted from Shenzhen Tongyi Industry's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Because of this, we think Shenzhen Tongyi Industry's earnings potential is at least as good as it seems, and maybe even better! And on top of that, its earnings per share increased by 35% in the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about Shenzhen Tongyi Industry as a business, it's important to be aware of any risks it's facing. At Simply Wall St, we found 2 warning signs for Shenzhen Tongyi Industry and we think they deserve your attention.
由於飛凡項目影響了上年的營業收入,因此我們可以預期當季業績將有所改善。因此,我們認爲同益股份的盈利潛力至少與表面看起來一樣好,甚至可能更好!而且,其每股盈利在上一年增長了35%。本文的目標是評估法定收益對反映公司潛力的可靠性,但還有很多因素需要考慮。如果您想了解更多關於同益股份作爲一家企業的信息,重要的是要意識到它面臨的任何風險。在Simply Wall St,我們發現了同益股份的2個風險預警信號,我們認爲這值得您關注。
Today we've zoomed in on a single data point to better understand the nature of Shenzhen Tongyi Industry's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
今天,我們將重點關注一個數據點,以更好地了解同益股份的利潤性質。但如果你能夠聚焦於細枝末節,總是有更多的發現。有些人認爲高淨資產收益率是一家優質企業的良好跡象。因此,您可能希望查看這些具有高淨資產收益率的公司的免費收藏,或者這些具有高內部持股的股票清單。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。